Senate Hearing On Ozempic, Wegovy Highlights Concerns About PBMs, International Price Disparities
Senate HELP Committee chair Sanders trying to broker a deal between Novo Nordisk and the major pharmacy benefit managers that will lead to lower list prices.
Learn what's happening at the US FDA. On the go.
